Last updated: 2026-11-14 16:01:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Lucid Diagnostics Inc. (LUCD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.46, with a market capitalization of $79.49M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.30 to $1.63. This page covers its latest market performance, valuation, price trends and company information.
$79.49M | |
$0.44 | |
$0.49 | |
$0.38 | |
$0.42 | |
3.27M | |
5.12M | |
-- | |
$1.63 | |
$0.30 | |
-- | |
-- |
Lucid Diagnostics Inc. (LUCD) last closed at $0.46 as of 2026-11-14 01:00:00, up 8.82% ($0.04) from the previous close of $0.42.
During the latest regular trading session, LUCD traded between $0.38 and $0.49, with a volume of 3.27M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Lucid Diagnostics Inc. (LUCD) moved from $0.39 to $0.46, representing a gain of 17.41% ($0.07).
The stock traded between $0.37 and $0.49 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.99 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 11.7%
LUCD is currently trading at $0.46, placing it 11.7% of the way from its 52-week low of $0.30 to its 52-week high of $1.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 82 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Lucid Diagnostics Inc. and LUCD stock.
Gainers Oragenics (AMEX:OGEN) stock increased by 30.2% to $0.46 during Thursday's after-market session. The market value of their outstanding shares is at $1.5 million. InspireMD (NASDAQ:NSPR) shares rose 13.88%
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 40 percent increase over losses of $(0.10) per share from the same period last year.
Eligible investors can buy real shares of Lucid Diagnostics Inc. (LUCD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LUCD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LUCD shares and USD.
LUCD Shares to USD
1.00 LUCD shares = 0.458 USD
Calculations are estimates based on the latest available price and are for reference only.
